Frequently Asked Questions
The U.S. blood plasma collection market size will be worth USD 8,289.06 million by 2031.
The growth rate of the U.S. blood plasma collection market is 6.3% during the forecast period by 2031.
The increasing aging population creates demand & government initiatives for safety and quality of product are the growth drivers of the U.S. blood plasma collection market.
Type, product type, method, application and end-user are the factors on which the U.S. blood plasma collection market research is based.
Major companies in the U.S. blood plasma collection market are STRECK (U.S.), SIO2 Material Science (U.S.), Grifols (Spain), Instech Laboratories, Inc. (U.S.), CSL Plasma (Australia), Greiner Bio-One International GmbH (Austria), Cardinal Health (U.S.), Retractable Technologies, Inc. (U.S.), BD (U.S.), Bio Products Laboratory Ltd. (U.S.), Hemarus Plasma (U.S.), Liminal Biosciences, Inc. (Canada), Vitalant (U.S.), Takeda Pharmaceutical Company Limited (Japan), Octapharma AG (Switzerland), Kedrion (Italy).
